EDNRA and pulmonary arterial hypertension: Furthermore, increased AT1R and ETAR antibodies have been demonstrated in systemic sclerosis and connective tissue disease-associated pulmonary arterial hypertension (10), cardiovascular disease, hypertension, and pre-eclampsia (6), which suggests that these antibodies are related to inflammation and vascular function.